Clinical Trial Update: Benefit of Left Atrial Roof Ablation in Paroxysmal Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the benefit of left atrial roof ablation in patients with drug-refractory paroxysmal atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Paroxysmal Atrial Fibrillation

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Drug-refractory Paroxysmal Atrial Fibrillation | Phase 3 | Status: COMPLETED